about
Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.Long-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration.Dynamics of blood count after rheohemapheresis in age-related macular degeneration: possible association with clinical changes.The importance of electrode position in visual electrophysiology.Changes of the complement system and rheological indicators after therapy with rheohemapheresis.Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis.Reduction in the drusenoid retinal pigment epithelium detachment area in the dry form of age-related macular degeneration 2.5 years after rheohemapheresis.Abnormalities of the long flash ERG in congenital stationary night blindness of the Schubert-Bornschein type.Age-related changes in retinal functional topography.The multifocal pattern electroretinogram (mfPERG) and cone-isolating stimuli.A comparison of the performance of three visual evoked potential-based methods to estimate visual acuity.Electrophysiology and colour: a comparison of methods to evaluate inner retinal function.Rheohaemapheresis in the treatment of nonvascular age-related macular degenerationExperience with extracorporeal elimination therapy in myasthenia gravisHaemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular formCascade Filtration in the Therapy of the Dry Form of Age-related Macular DegenerationThe importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresisPigmentary retinopathy can indicate the presence of pathogenic LAMP2 variants even in somatic mosaic carriers with no additional signs of Danon disease
P50
Q33734287-D058936E-066F-475D-ABC5-B66C99B3E21EQ37433013-13D023C1-DF9A-42D3-AE8B-CDFDB3FD30A3Q37664653-D94C3FF3-3409-47A8-83FE-771850FC9F97Q38948945-604BFF24-9B82-48D5-9E4F-378304E3091EQ40983359-9A0BAE0D-D775-4039-8121-5FB0CD414B2AQ41961146-8CC95493-8345-4262-BE3F-D9AEAD03363BQ43821415-90EB3658-AE7E-4C4D-8176-BD5EB24092B8Q44014596-10B21242-8771-4C4C-823D-1CF556F78C5EQ46251894-326D42EB-0180-4A4D-B211-6DA1A5923967Q46841373-75D32969-8AF9-4EA1-B7C4-3D0CCB6171A3Q49050242-9945BD17-31B0-4AA5-875D-E2641A4F091EQ50209454-D29B0E3A-3D87-43AC-B347-4A0F728A6CB9Q58860413-D96C4EAD-8770-4E02-B359-754D137C8AC8Q58860416-23F4D61C-88C1-4E8C-91E5-78F4ABCEC574Q58860417-E7D8A499-9AE6-44E6-88A3-FA02602B9C27Q58860419-846EE0CD-80C9-495D-A4E3-0E540D8BCE1CQ83221389-D9529BA4-37DC-4DB4-A907-9C32B1F58813Q96350252-9434E1DD-A0DC-48F2-A187-50F23004A3CF
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-8488-7208
@en
name
Hana Langrová
@an
Hana Langrová
@ast
Hana Langrová
@br
Hana Langrová
@ca
Hana Langrová
@co
Hana Langrová
@cs
Hana Langrová
@da
Hana Langrová
@de
Hana Langrová
@en
Hana Langrová
@es
type
label
Hana Langrová
@an
Hana Langrová
@ast
Hana Langrová
@br
Hana Langrová
@ca
Hana Langrová
@co
Hana Langrová
@cs
Hana Langrová
@da
Hana Langrová
@de
Hana Langrová
@en
Hana Langrová
@es
prefLabel
Hana Langrová
@an
Hana Langrová
@ast
Hana Langrová
@br
Hana Langrová
@ca
Hana Langrová
@co
Hana Langrová
@cs
Hana Langrová
@da
Hana Langrová
@de
Hana Langrová
@en
Hana Langrová
@es
P106
P1153
6701738188
P21
P31
P496
0000-0001-8488-7208